Tom Ryu

455 total citations
25 papers, 237 citations indexed

About

Tom Ryu is a scholar working on Epidemiology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tom Ryu has authored 25 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 12 papers in Pathology and Forensic Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tom Ryu's work include Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (10 papers) and Diet, Metabolism, and Disease (6 papers). Tom Ryu is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Alcohol Consumption and Health Effects (10 papers) and Diet, Metabolism, and Disease (6 papers). Tom Ryu collaborates with scholars based in South Korea, United States and Puerto Rico. Tom Ryu's co-authors include Keungmo Yang, Won‐Il Jeong, Ye Eun Kim, Jun Hee Lee, Hyuk Soo Eun, Seok‐Hwan Kim, Hee‐Hoon Kim, Won‐Mook Choi, Jong‐Min Jeong and Je‐Hyun Yoon and has published in prestigious journals such as PLoS ONE, Hepatology and Scientific Reports.

In The Last Decade

Tom Ryu

19 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Ryu South Korea 7 105 98 61 56 52 25 237
Christina K. Cajigas‐Du Ross United States 7 106 1.0× 106 1.1× 34 0.6× 31 0.6× 31 0.6× 8 276
Johanna Reißing Germany 7 49 0.5× 93 0.9× 42 0.7× 16 0.3× 70 1.3× 16 186
Yiming Lei China 8 174 1.7× 65 0.7× 36 0.6× 119 2.1× 37 0.7× 15 293
Luis Leiva‐Vega Spain 7 116 1.1× 91 0.9× 26 0.4× 26 0.5× 35 0.7× 11 276
Nancy M. Benight United States 13 139 1.3× 30 0.3× 97 1.6× 31 0.6× 61 1.2× 16 394
Yuzo Koda Japan 8 79 0.8× 140 1.4× 119 2.0× 15 0.3× 104 2.0× 14 312
Lianqing Lou China 12 166 1.6× 136 1.4× 18 0.3× 127 2.3× 103 2.0× 22 361
Jayashree Bagchi Chakraborty United Kingdom 5 97 0.9× 153 1.6× 111 1.8× 25 0.4× 120 2.3× 5 328
Xianghui Wu China 10 115 1.1× 118 1.2× 52 0.9× 19 0.3× 101 1.9× 19 307
Shunsuke Shiba Japan 10 59 0.6× 118 1.2× 67 1.1× 12 0.2× 95 1.8× 14 253

Countries citing papers authored by Tom Ryu

Since Specialization
Citations

This map shows the geographic impact of Tom Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Ryu more than expected).

Fields of papers citing papers by Tom Ryu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Ryu. The network helps show where Tom Ryu may publish in the future.

Co-authorship network of co-authors of Tom Ryu

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Ryu. A scholar is included among the top collaborators of Tom Ryu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Ryu. Tom Ryu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Tom, Young Woon Chang, Jeong‐Ju Yoo, et al.. (2025). Glucosamine supplementation attenuates progression of metabolic dysfunction-associated steatotic liver disease and related comorbidities. Clinical Nutrition. 47. 119–128. 1 indexed citations
2.
Ryu, Tom, Young Woon Chang, Soung Won Jeong, et al.. (2025). Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C. Clinical and Molecular Hepatology. 31(2). 548–562.
3.
4.
5.
Ryu, Tom, Jae Jun Lee, Ji Won Han, et al.. (2025). Multivitamin supplementation and its impact in metabolic dysfunction-associated steatotic liver disease. Scientific Reports. 15(1). 8675–8675. 3 indexed citations
6.
Yang, Keungmo, et al.. (2025). Alcohol-Induced Oxidative Stress and Gut–Liver–Brain Crosstalk: Expanding the Paradigm from ALD to MetALD. Antioxidants. 14(10). 1196–1196. 1 indexed citations
7.
Yang, Keungmo, Jae Jun Lee, Ji Won Han, et al.. (2025). The prognostic impact of statin exposure in metabolic dysfunction-associated steatotic liver disease: a cohort study. Translational Gastroenterology and Hepatology. 10. 61–61.
8.
Chung, Beom Sun, Keungmo Yang, Chihyun Park, & Tom Ryu. (2025). Prolonged Intestinal Ethanol Absorption and Oxidative Stress: Revisiting the Gut–Liver Axis in Alcohol-Associated Disease. International Journal of Molecular Sciences. 26(12). 5442–5442. 1 indexed citations
9.
10.
Yang, Keungmo, Tom Ryu, & Beom Sun Chung. (2024). Psyllium fiber improves hangovers and inflammatory liver injury by inhibiting intestinal drinking. Frontiers in Pharmacology. 15. 1378653–1378653. 2 indexed citations
11.
Jang, Jae Young, Tom Ryu, Young Woon Chang, Soung Won Jeong, & Seong Sook Hong. (2024). Eosinophilic Liver Abscess that Needs to be Differentiated from Malignant Tumor. 9(2). 102–104.
12.
Yang, Keungmo, Tom Ryu, & Beom Sun Chung. (2023). A Meta-Analysis of Preclinical Studies to Investigate the Effect of Panax ginseng on Alcohol-Associated Liver Disease. Antioxidants. 12(4). 841–841. 4 indexed citations
13.
Kim, Hee‐Hoon, Ha‐Neul Kim, Keungmo Yang, et al.. (2023). xCT-mediated glutamate excretion in white adipocytes stimulates interferon-γ production by natural killer cells in obesity. Cell Reports. 42(6). 112636–112636. 7 indexed citations
14.
Yang, Keungmo, et al.. (2023). Comprehensive transcriptomic analysis and meta-analysis identify therapeutic effects of N-acetylcysteine in nonalcoholic fatty liver disease. Frontiers in Pharmacology. 14. 1186582–1186582. 3 indexed citations
15.
16.
Chang, Young Woon, Jae‐A Han, Soung Won Jeong, et al.. (2021). Clinical impact of serum exosomal microRNA in liver fibrosis. PLoS ONE. 16(9). e0255672–e0255672. 18 indexed citations
17.
Kim, Myung Ho, Jong‐Min Jeong, Jun Hee Lee, et al.. (2020). Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells. Journal of Ginseng Research. 44(6). 815–822. 23 indexed citations
18.
Lee, Joon Seong, Hyun‐Sook Kim, Tom Ryu, et al.. (2020). Esophageal Involvement and Determinants of Perception of Esophageal Symptoms Among South Koreans With Systemic Sclerosis. Journal of Neurogastroenterology and Motility. 26(4). 477–485. 10 indexed citations
19.
Kim, Tae Yeob, Ki Tae Suk, Soung Won Jeong, et al.. (2019). The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients. Journal of Korean Medical Science. 34(33). e223–e223. 4 indexed citations
20.
Lee, Jun Hee, Wonhyo Seo, Won‐Mook Choi, et al.. (2019). Mitochondrial Double‐Stranded RNA in Exosome Promotes Interleukin‐17 Production Through Toll‐Like Receptor 3 in Alcohol‐associated Liver Injury. Hepatology. 72(2). 609–625. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christina K. Cajigas‐Du Ross Breakdown of academic impact, for papers by Johanna Reißing Breakdown of academic impact, for papers by Yiming Lei Breakdown of academic impact, for papers by Luis Leiva‐Vega Breakdown of academic impact, for papers by Nancy M. Benight Breakdown of academic impact, for papers by Yuzo Koda Breakdown of academic impact, for papers by Lianqing Lou Breakdown of academic impact, for papers by Jayashree Bagchi Chakraborty Breakdown of academic impact, for papers by Xianghui Wu Breakdown of academic impact, for papers by Shunsuke Shiba
Rankless by CCL
2026